Celgene

27 results

Amgen said it expects the deal to produce tax benefits with a present cash value of $2.2 billion. Photograph: Getty Images

Amgen will buy Celgene’s psoriasis drug Otezla for $13.4 billion (€12.05 billion) in cash, clearing the way for Bristol-Myers Squibb to go ahead with (...)

Pfizer has been trying to reposition itself as a smaller company focused on more innovative medicines and vaccines.

Pfizer is expected to announce on Monday that it will combine its off-patent assets with Mylan’s $10 billion (€9 billion) generics business in a stock(...)

Lip service: AbbVie has been desperate to fill in the gap for its blockbuster arthritis drug Humira, which loses patent protection in 2023. Allergan, best known as the maker of Botox, fits the bill. Photograph: Alan Betson

Botox can fill even the most obstinate wrinkles but the botulinum toxin contained in injections can cause unexpected sagging too. On Tuesday, pharma g(...)

Traders work on the floor at the New York Stock Exchange   in New York, US. Photograph: Brendan McDermid/Reuters

Weak German economic data and a profit warning from Daimler hit European stock markets on Monday as investors reined in any bets on a fourth week of g(...)

Brexit troubles didn’t  have a consistent impact on Irish shares on Friday. Photograph: Toby Melville/Reuters

Brexit uncertainty failed to trouble the Republic’s main share index on Friday while other European indices gained primarily due to signs of progress (...)

Earnings from one of the Iseq’s most significant component companies boosted the index by 0.76 per cent on Thursday. Photograph: Dara Mac Dónaill

Irish stocks were a bright spot among peers on Thursday as global equities declined on the back of an abrupt ending to US president Donald Trump’s mee(...)

Loxo is developing cancer treatments that target a tumors’ genetic markers regardless of where in the body they’re located

US pharma giant Eli Lilly is to buy Loxo Oncology for about $8 billion (€7 billion) in cash, the second multibillion-dollar cancer deal of the year by(...)

Apple’s first sales warning in over a decade sent European shares sliding, with the tech sector particularly badly bruised as chipmakers that supply the iPhone maker fell sharply. Photograph: Getty Images

A revenue warning from Apple rocked equity markets around the globe yesterday as concerns over a damaging China-US trade battle and its impact on worl(...)

The deal aims to create a pharmaceutical leader in cancer and immunologic disease treatments. Photograph: iStock

Bristol-Myers Squibb, the US drugmaker, has agreed to buy Celgene in a cash and stock deal valuing the rival drugmaker at roughly $90 billion includin(...)

Dr Elaine Sullivan, co-founder and chief executive of early-stage life-sciences company Carrick Therapeutics, has been chosen as The Irish Times Busin(...)

  • 1
  • 2
  • 3
  • Next
  • Last »